Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Oct 29;11:397–405. doi: 10.2147/JIR.S174326

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Floris et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Single donor responses to diluted placebo or active globules.

Notes: The graphs in the figure represent the percentage of IL-1β (A, B), TNF-α (C, D), and IL-6 (E, F) release (vs LPS control, 100%) of primary enriched monocytes from 6 donors, exposed to 10 ng/mL of LPS for 24 hours and treated with 1 capsule of 2LARTH^® (Active) or placebo at 2 lactose-saccharose globules concentrations (11 and 22 mM). Data are expressed as mean ± SD percentage (vs LPS control, 100%).

Abbreviations: LPS, lipopolysaccharide; TNF, tumor necrosis factor.